Bone Biologics Stock Price, News & Analysis
bblgw
NASDAQ
Company Description
Welcome to the overview page for Bone Biologics (bblgw), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Financial Highlights
-$4.1M
Net Income (TTM)
$-4.83
-$4.1M
Operating Cash Flow
10.22
-$4.2M
—
Revenue (TTM)
Upcoming Events
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Bone Biologics (bblgw)?
The current stock price of Bone Biologics (bblgw) is $31 as of February 12, 2026.
What is the net income of Bone Biologics (bblgw)?
The trailing twelve months (TTM) net income of Bone Biologics (bblgw) is -$4.1M.
What is the earnings per share (EPS) of Bone Biologics (bblgw)?
The diluted earnings per share (EPS) of Bone Biologics (bblgw) is $-4.83 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of Bone Biologics (bblgw)?
The operating cash flow of Bone Biologics (bblgw) is -$4.1M. Learn about cash flow.
What is the current ratio of Bone Biologics (bblgw)?
The current ratio of Bone Biologics (bblgw) is 10.22, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Bone Biologics (bblgw)?
The operating income of Bone Biologics (bblgw) is -$4.2M. Learn about operating income.